Lung ultrasound (LUS) has emerged as a valuable tool for assessing COVID-19-related lung abnormalities. Key ultrasound findings in COVID-19 include diffuse B-lines (indicating interstitial syndrome), thickened and irregular pleural lines, subpleural consolidations, and less commonly, pleural effusions. These findings help clinicians evaluate disease severity, monitor progression, and guide therapeutic interventions, often serving as a rapid, radiation-free alternative to CT scans.
For medical and ultrasound professionals, understanding COVID-19 LUS findings is crucial for early diagnosis and effective management. The characteristic patterns observed, such as multifocal B-lines in a patchy or confluent distribution, can aid in differentiating COVID-19 pneumonia from other respiratory conditions. This non-invasive imaging modality offers a practical approach for bedside assessment in resource-limited settings and for repeated evaluations in critical care.
